COVID

Discovery of drugs to treat cytokine storm-induced cardiac dysfunction using human cardiac organoids

COVID-19 causes cardiac injury and dysfunction in 20-30% of patients. Using human cardiac organoids combined with high sensitivity phosphoproteomics, we identify the drug INCB054329 as a prime candidate for drug repurposing to attenuate cardiac dysfunction and improve COVID-19 mortality in humans.